Funding

LEXINGTON, Mass. – November 05, 2026 -- Curis, Inc. (NASDAQ: CRIS) will report third-quarter 2026 financial and operating results on Thursday, November 12, 2026, at 4:00 p.m. ET, with a conference call and webcast following at 4:30 p.m. ET.

Curis ties acute myeloid leukemia expansion to new funding

The company's monotherapy and combination studies of emavusertib in acute myeloid leukemia (AML) are substantially complete. Curis plans to continue AML development only with additional funding, which makes the November 12 update a checkpoint on its financial position.

Berlin – November 03, 2026 -- Seventy-two percent of German civil society organizations look to their future with confidence, even as 73% name bureaucracy and administrative burden as a key obstacle, according to the first Zuversichtsbarometer ("confidence barometer") from the Robert Bosch Stiftung.

Polling firm forsa surveyed 754 representatives of registered associations (e. V.), foundations and nonprofit limited companies (gGmbHs). The organizations cover welfare, education, environment, culture and sport. Interviews were conducted by computer-assisted telephone (CATI) from August 10 to September 4, 2026.

Staff engagement drives optimism for 94% of respondents

Employee and volunteer commitment is the most important source of encouragement, cited by 94%. Positive feedback from target groups follows at 92%, and tangible successes and visible impact at 90%.